• Anagliptin (SK-0403): DPP-4 Inhibition and Vascular Assay Ad

  2026-05-27

  Anagliptin (SK-0403) uniquely empowers researchers to dissect both glycemic and vascular mechanisms, bridging DPP-4 inhibition with direct modulation of Kv channels and SERCA pumps. This article translates the latest vasorelaxant findings into actionable protocols, troubleshooting, and comparative insights for high-precision diabetes and cardiovascular research.

• SERPINH1–MMP-9/TGFβ1 Feedback Drives Lung Adenocarcinoma Pro

  2026-05-26

  This study uncovers a positive feedback loop between SERPINH1 and the MMP-9/TGFβ1 axis that fuels lung adenocarcinoma progression and metastasis. The findings clarify how SERPINH1 stabilizes MMP-9, enhances TGF-β1 signaling, and activates cancer-associated fibroblasts, highlighting new avenues for targeted intervention and cell proliferation analysis.

• DFO (9H-1,8-Diazafluoren-9-one): Forensic Fingerprint Fluore

  2026-05-26

  DFO (9H-1,8-Diazafluoren-9-one) is a validated fluorescent dye for latent fingerprint detection on porous substrates. Its amino acid reactivity enables high-sensitivity forensic visualization, and its rigorous quality is supported by APExBIO. Key protocol parameters and limitations are detailed below.

• Amyloid Beta-Peptide (1-40): New Mechanisms, Translational I

  2026-05-25

  This thought-leadership article explores the evolving role of Amyloid Beta-Peptide (1-40) (human) in Alzheimer’s disease research, highlighting novel mechanistic insights into microglial regulation, best practices in experimental design, and strategic guidance for translational scientists. Drawing upon both emerging evidence and advanced workflows, the discussion frames Amyloid Beta-Peptide (1-40) as a benchmark tool for next-generation neurodegeneration research and translational innovation.

• Imidazoline Blockade of β-Cell K+ Channels: Pathway to Enhan

  2026-05-25

  This article examines how imidazoline antagonists of α2-adrenoceptors, notably phentolamine and its analogs, increase insulin secretion in vitro by inhibiting ATP-sensitive potassium channels in pancreatic β-cells. The study's findings clarify the mechanism underlying drug-induced insulin release, with implications for diabetes research and ion channel pharmacology.

• SHC-1 Inhibition Modulates CFTR Trafficking in Epithelial Mo

  2026-05-24

  This study investigates how SHC-1 inhibition affects the plasma membrane abundance of the CFTR chloride channel in diverse epithelial cell models. The findings illuminate conserved and cell-specific regulatory mechanisms governing CFTR trafficking, with implications for cystic fibrosis and secretory disease research.

• Sumatriptan Succinate: Precision Tools for Pediatric Migrain

  2026-05-23

  Explore the advanced use of Sumatriptan Succinate as a 5-HT1 receptor agonist in pediatric migraine research. This article uniquely bridges mechanistic detail with translational assay design, highlighting insights from recent clinical and preclinical studies.

• EdU Imaging Kits (HF488): Precision Cell Proliferation Detec

  2026-05-22

  EdU Imaging Kits (HF488) enable sensitive, high-specificity cell proliferation assays by detecting 5-ethynyl-2'-deoxyuridine incorporation into DNA. This kit uses click chemistry for direct S-phase detection, offering advantages over traditional BrdU methods and supporting robust analysis by fluorescence microscopy or flow cytometry.

• EdU Imaging Kits (Cy5): Precision Tools for Tumor Microenvir

  2026-05-22

  Explore how EdU Imaging Kits (Cy5) enable precise S-phase DNA synthesis measurement and transform cell proliferation analysis in tumor microenvironment studies. This article offers advanced technical insight and practical guidance beyond standard protocol comparisons.

• Cell Senescence β-Galactosidase Staining Kit: Precision in S

  2026-05-21

  Leverage the Cell Senescence β-Galactosidase Staining Kit to achieve artifact-free, high-specificity detection of senescent cells in aging research and drug screening. Discover actionable protocol enhancements, troubleshooting tips, and insights from recent senolytic breakthroughs that set this SA-β-Gal staining kit apart.

• Pyranocoumarins from A. dahurica Inhibit LPS-Induced Inflamm

  2026-05-21

  This study elucidates how bioactive pyranocoumarins from Angelica dahurica roots suppress LPS-induced inflammation in macrophages by dual inhibition of MAPK and NF-κB signaling. The findings mechanistically validate the traditional anti-inflammatory use of A. dahurica and highlight key compounds for further exploration in inflammatory disease models.

• Icariin Modulates SSC Proliferation via PDE5A: Mechanisms an

  2026-05-20

  The referenced study elucidates how Icariin, a compound from traditional Chinese medicine, enhances the proliferation and DNA repair of mouse spermatogonial stem cells (SSCs) by targeting PDE5A. These findings provide a mechanistic framework for male fertility interventions and highlight advanced cell proliferation detection strategies applicable in reproductive research.

• EdU Imaging Kits (HF488): Powering Translational Oncology

  2026-05-20

  Explore how EdU Imaging Kits (HF488) leverage advanced click chemistry for precision cell proliferation analysis, bridging mechanistic insight with translational strategy. This article integrates recent breakthroughs—such as metabolic reprogramming in renal cell carcinoma and the impact of gingerenone A—with practical guidance, protocol parameters, and a forward-looking perspective on the evolving landscape of proliferation assays in drug development and clinical research.

• QSHXO Ameliorates MASLD via Autophagy and Ferroptosis Modula

  2026-05-19

  Liu et al. demonstrate that Qushi Huoxue ointment (QSHXO) mitigates metabolic associated steatotic liver disease (MASLD) in mice by promoting autophagy and inhibiting ferroptosis, with mechanistic validation at both molecular and ultrastructural levels. These findings clarify how coordinated modulation of these cellular pathways can attenuate liver injury, providing a mechanistic foundation for targeted MASLD research.

• JNJ-26481585 (Quisinostat): Applied HDAC Inhibition in Tumor

  2026-05-19

  JNJ-26481585 (Quisinostat) offers precise, potent HDAC inhibition for driving apoptosis and reversing drug resistance in challenging tumor research models. This guide translates breakthrough TRIM21-ERK1/2 findings into actionable protocols, troubleshooting strategies, and advanced applications, ensuring researchers can leverage this epigenetic modulator for maximal experimental impact.

554 records 17/37 page Previous Next First page 上5页 1617181920 下5页 Last page